Navigation Links
VisionCare's Macular Degeneration Telescope Implant Named 'Best of What's New' 2010 by Popular Science
Date:11/17/2010

nals including Ophthalmology, American Journal of Ophthalmology, and Archives of Ophthalmology showed that patients achieved clinically meaningful gains in visual acuity and quality of life with the telescope implant.

CentraSight Treatment Program

The first-of-kind telescope implant is integral to a new patient care program, CentraSight, for treating patients with end-stage macular degeneration. The CentraSight treatment program involves a patient management process and access to reimbursement resources for patients and physicians. The telescope implantation is performed by a specially trained ophthalmic surgeon as an outpatient procedure.

Patients and physicians can find more information about the telescope implant and related treatment program at www.centrasight.com.

VisionCare submitted an application to the Centers of Medicare and Medicaid Services for a new code to establish Medicare beneficiary access to this implantation procedure. It is anticipated that CentraSight evaluations and surgeries will commence shortly after Medicare finishes its code evaluation.

About the Telescope Implant

The Implantable Miniature Telescope (by Dr. Isaac Lipshitz) is indicated for monocular implantation to improve vision in patients greater than or equal to 75 years of age with stable severe to profound vision impairment (best-corrected distance visual acuity 20/160 to 20/800) caused by bilateral central scotomas (blind areas) associated with end-stage AMD. This level of visual impairment constitutes statutory (legal) blindness.

The telescope is implanted in one eye in an outpatient surgical procedure. In the implanted eye, the device renders enlarged central vision images over a wide area of the retina to improve central vision, while the non-operated eye provides peripheral vision for mobility and orientation.

The most common risks of the telescop
'/>"/>

SOURCE VisionCare Ophthalmic Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
2. Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
3. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
4. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
5. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
6. Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
7. Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)
8. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
9. TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
10. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
11. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 A six-hour certification program ... being presented at the Cannabis World Congress & Business ... New York, NY .  Taking place on Wednesday, June ... day of education at the leading event on the East ... Led by Clover Leaf University, the first cannabis university ...
(Date:5/29/2015)... , May 29, 2015  Dr. Yair Walzer ... to resolve vaginal health issues often caused by menopause. The ... requires no anesthesia, received FDA clearance in 2014. Dr. Walzer ... to offer the special fractional CO 2 ... breast cancer survivors. In 2010 there were ...
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2
... Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and ... of a new education campaign designed to help answer ... a reference tool to supplement their discussions about vaccination ... provides consumer-friendly, accurate and science-based information about immunization that ...
... DEERFIELD, Ill., Nov. 17, 2011 Today, Takeda ... (dexlansoprazole) product labeling now includes information from a ... no clinically important effect on exposure to the ... No dose adjustment of clopidogrel is necessary when ...
Cached Medicine Technology:Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 2Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 3Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 2DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 3DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 5
(Date:5/29/2015)... To compile the list, the Becker's ... have several awards for clinical and general excellence. The ... out to them in terms of overall excellence, and ... The 50 Great Health Systems to Know 2015 list ... Springs, Fla.) , Advocate Health Care (Downers Grove, Ill.) ...
(Date:5/29/2015)... May 29, 2015 The Healthcare ... graduates of its Advanced Training Program (ATP) in ... fill roles in their health care organization ranging ... and methodology of continuous quality improvement in the ... to Dr. Brent James’ internationally recognized Advanced Training ...
(Date:5/29/2015)... New York (PRWEB) May 29, 2015 ... of patented products, announces that it has signed a ... a technology patent that aims to let people learn ... experts in real time. , "This is an exciting ... Room " said Scott J. Cooper, CEO and Creative ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching ... many life coaches have asked, "How do I find ... to become a credentialed Coach?" , Many Life and ... long. Inspire Nexus, a social network for Coaches provides ... have experience coaching a certain number of hours, qualify ...
(Date:5/29/2015)... May 29, 2015 Mediaplanet has joined ... educate readers on the importance of proper sun protection. ... USA Today, with a circulation of approximately 250,000 copies ... component is distributed nationally, through a vast social media ... and partner outlets. To explore the digital version of ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... of long-term use still outweigh possible benefits , SUNDAY, ... seemed like a wonderful means to help women age ... as their bodies began to produce decreased amounts of ... heart disease, osteoporosis and cancer. , But those beliefs ...
... the annual meeting of the American Sociological Association. Below are ... COUNTRY Gay depictions in the media have "exploded" in ... youth still find it difficult to find people like them on ... to help them come to terms with their sexual identity and ...
... undergoes surgery, follow these helpful tips , SATURDAY, Aug. 8 ... undergoing surgery, it helps if parents and children are well-prepared, ... can be a source of stress for a person of ... whole new layer of sensitivity is added," ASA President Dr. ...
... health-care system perspective, it may be more efficient to use ... have a wild-type KRAS gene, according to a study published ... Cancer Institute . Earlier, patients whose tumors harbored wild-type ... treated with cetuximab in a randomized trial by the National ...
... , , Provides Protection for People with ... WASHINGTON, Aug. 7 The Lupus Foundation of America (LFA) President ... regarding S.1630 "The Affordable Access to Prescription Medications Act of ... (Jay) D. Rockefeller IV (D-WV). , , ...
... , , MORRISTOWN, N.J., ... a leading specialty pharmaceutical company, announced today that one lot of ... is being voluntarily recalled from wholesalers and pharmacies. The recalled ... 2011 and were manufactured by Watson Laboratories, Inc. and distributed by ...
Cached Medicine News:Health News:In U.S., No Comeback Seen for Hormone Therapy 2Health News:In U.S., No Comeback Seen for Hormone Therapy 3Health News:Indiana University research at the American Sociological Association annual meeting 2Health News:Indiana University research at the American Sociological Association annual meeting 3Health News:Indiana University research at the American Sociological Association annual meeting 4Health News:Good Planning Paves Way for Kid's Operation 2Health News:Cost-effectiveness of cetuximab in metastatic colorectal cancer 2Health News:The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 3
... assay is an immunometric ('sandwich') EIA ... in human serum or plasma. LH ... 2 monoclonal anti-LH antibodies directed at ... to magnetic particles and the other ...
... Luteinizing hormone (LH) is a glycoprotein ... the FSH, hCG and TSH, the intact ... alpha- and beta-subunits. These glycoproteins all have ... unique beta-subunit. Both LH and FSH production ...
... StreamLAB combines consolidated ... Systems with pre- and ... an innovative laboratory automation ... needs of today's laboratories, ...
... simplifies and enhances critical care ... features such as its self-contained ... options, the GEM Premier 3000 ... (iQM), an internal, automated program ...
Medicine Products: